Laropiprant

Cibenzoline Succinate, (s)-

cibenzoline succinate, (s)-

Dosage form: POWDER. Active ingredients: CIFENLINE SUCCINATE, (S)- (1 kg/kg). Category: BULK INGREDIENT.

Echinacea, Bryonia, Camphora, Cistus Canadensis, Drosera, Hepar Sulphuris Calcareum, Hydrastis Canadensis, Ignatia Amara, Iodium, Kali Bichromicum, Kali Iodatum, Phosphorus, Pulsatilla, Sabadilla, Silicea, Sticta Pulmonaria, Sulphur, Teucrium Marum, Verbascum Thapsus, Arsenicum Album, Belladonna, Histaminum Hydrochloricum, Lac Caninum, Nux Vomica

echinacea, bryonia, camphora, cistus canadensis, drosera, hepar sulphuris calcareum, hydrastis canadensis, ignatia amara, iodium, kali bichromicum, kali iodatum, phosphorus, pulsatilla, sabadilla, silicea, sticta pulmonaria, sulphur, teucrium marum, verbascum thapsus, arsenicum album, belladonna, histaminum hydrochloricum, lac caninum, nux vomica

Non-Standardized Plant Allergenic Extract [EPC]

OTC - PURPOSE SECTION Formulated for associated symptoms such as congestion, constriction, gland swelling, tension and inflammation.

Xylocaine(r) -mpf (lidocaine Hci And Epinephrine)

xylocaine(r) -mpf (lidocaine hci and epinephrine)

DESCRIPTION Xylocaine (lidocaine HCl) Injections are sterile, nonpyrogenic, aqueous solutions that contain a local anesthetic agent with or without epinephrine and are administered parenterally by injection. See INDICATIONS & USAGE section for specific uses. Xylocaine solutions contain lidocaine HCl, which is chemically designated as acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-, monohydrochloride and has the molecular wt. 270.8.